Clearside Biomedical Ownership 2024 | Who Owns Clearside Biomedical Now?
Institutional Ownership
6.08%
Insider Ownership
7.42%
Retail Ownership
86.49%
Institutional Holders
16.00
Clearside Biomedical Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.07% | 0.00% | 2,839,978 | 349,182 | 14.02% | 3,691,971 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 3.71% | 2.59% | 2,592,593 | - | - | 3,370,371 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 3.06% | 0.03% | 2,136,000 | -1,820,000 | -46.01% | 2,776,800 | Jun 30, 2024 |
| CARMIGNAC GESTION | 3.05% | 0.05% | 2,132,744 | - | - | 2,772,567 | Jun 30, 2024 |
| BLACKROCK INC. | 1.14% | - | 798,137 | 39,911 | 5.26% | 1,037,579 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.96% | 0.00% | 672,297 | 30,084 | 4.68% | 874,173 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.83% | 0.00% | 582,689 | 35,900 | 6.57% | 757,496 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.41% | 0.00% | 283,193 | 283,193 | 100.00% | 368,151 | Jun 30, 2024 |
| STATE STREET CORP | 0.29% | - | 205,163 | 11,800 | 6.10% | 266,712,000 | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | 0.25% | 0.00% | 175,000 | - | - | 227,500 | Jun 30, 2024 |
| MORGAN STANLEY | 0.21% | - | 145,990 | -7,054 | -4.61% | 189,787 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.19% | - | 133,451 | -84 | -0.06% | 173,486,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 130,000 | -200 | -0.15% | 169,000 | Jun 30, 2024 |
| BROWN WEALTH MANAGEMENT, LLC | 0.14% | 0.05% | 100,000 | -10,000 | -9.09% | 130,000 | Jun 30, 2024 |
| NORTHEAST FINANCIAL CONSULTANTS INC | 0.13% | 0.01% | 93,000 | - | - | 120,900 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.12% | 0.00% | 87,000 | 37,000 | 74.00% | 113,100 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.09% | 0.00% | 62,117 | -6,346 | -9.27% | 80,752 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 54,313 | 34,359 | 172.19% | 70,607 | Jun 30, 2024 |
| SYNOVUS FINANCIAL CORP | 0.08% | 0.00% | 53,071 | - | - | 68,992 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.06% | - | 42,889 | -164,038 | -79.27% | 55,756 | Jun 30, 2024 |
Clearside Biomedical's largest institutional shareholder is VANGUARD GROUP INC, holding 4.07% of the company's total share outstanding, currently valued at $3.69M. The top 10 institutional shareholders own together 17.78% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROSALIND ADVISORS, INC. | 3.71% | 2.59% | 2,592,593 | - | - | 3,370,371 | Jun 30, 2024 |
| BROWN WEALTH MANAGEMENT, LLC | 0.14% | 0.05% | 100,000 | -10,000 | -9.09% | 130,000 | Jun 30, 2024 |
| CARMIGNAC GESTION | 3.05% | 0.05% | 2,132,744 | - | - | 2,772,567 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 3.06% | 0.03% | 2,136,000 | -1,820,000 | -46.01% | 2,776,800 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 54,313 | 34,359 | 172.19% | 70,607 | Jun 30, 2024 |
| NORTHEAST FINANCIAL CONSULTANTS INC | 0.13% | 0.01% | 93,000 | - | - | 120,900 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 130,000 | -200 | -0.15% | 169,000 | Jun 30, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 20,000 | -16,000 | -44.44% | 26,000 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.06% | 0.00% | 40,000 | - | - | 52,000 | Jun 30, 2024 |
| ROCKWOOD WEALTH MANAGEMENT, LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 13,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.83% | 0.00% | 582,689 | 35,900 | 6.57% | 757,496 | Jun 30, 2024 |
| SYNOVUS FINANCIAL CORP | 0.08% | 0.00% | 53,071 | - | - | 68,992 | Jun 30, 2024 |
| STRATOS WEALTH ADVISORS, LLC | 0.02% | 0.00% | 14,000 | - | - | 18,200 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.41% | 0.00% | 283,193 | 283,193 | 100.00% | 368,151 | Jun 30, 2024 |
| RMB CAPITAL MANAGEMENT, LLC | 0.04% | 0.00% | 25,000 | - | - | 32,500 | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | 0.25% | 0.00% | 175,000 | - | - | 227,500 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.12% | 0.00% | 87,000 | 37,000 | 74.00% | 113,100 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 15,898 | 8,001 | 101.32% | 20,667 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.03% | 0.00% | 18,802 | -3,205 | -14.56% | 24,443 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.09% | 0.00% | 62,117 | -6,346 | -9.27% | 80,752 | Jun 30, 2024 |
The largest Clearside Biomedical shareholder by % of total assets is ROSALIND ADVISORS, INC.. The company owns 2.59M shares of Clearside Biomedical (CLSD), representing 2.59% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.07% | 0.00% | 2,839,978 | 349,182 | 14.02% | 3,691,971 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.41% | 0.00% | 283,193 | 283,193 | 100.00% | 368,151 | Jun 30, 2024 |
| BLACKROCK INC. | 1.14% | - | 798,137 | 39,911 | 5.26% | 1,037,579 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.12% | 0.00% | 87,000 | 37,000 | 74.00% | 113,100 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.83% | 0.00% | 582,689 | 35,900 | 6.57% | 757,496 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 54,313 | 34,359 | 172.19% | 70,607 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.96% | 0.00% | 672,297 | 30,084 | 4.68% | 874,173 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.03% | - | 20,788 | 20,788 | 100.00% | 27,024 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.05% | 0.00% | 35,400 | 15,200 | 75.25% | 46,020 | Jun 30, 2024 |
| STATE STREET CORP | 0.29% | - | 205,163 | 11,800 | 6.10% | 266,712,000 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.01% | - | 10,000 | 10,000 | 100.00% | 13,000 | Jun 30, 2024 |
| ROCKWOOD WEALTH MANAGEMENT, LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 13,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 15,898 | 8,001 | 101.32% | 20,667 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 6,634 | 1,305 | 24.49% | 8,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 568 | 568 | 100.00% | 1,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 6,091 | 443 | 7.84% | 7,918 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 243 | 243 | 100.00% | 316 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | 2 | - | - | 3 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 1,092 | - | - | 1,419 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | - | 1,100 | - | - | 1,375 | Jun 30, 2024 |
As of Jun 30 2024, Clearside Biomedical's largest institutional buyer is VANGUARD GROUP INC. The company purchased 349.18K stocks of CLSD, valued at $3.69M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 3.06% | 0.03% | 2,136,000 | -1,820,000 | -46.01% | 2,776,800 | Jun 30, 2024 |
| JOHNSON & JOHNSON | - | - | - | -169,629 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.06% | - | 42,889 | -164,038 | -79.27% | 55,756 | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | - | - | - | -161,962 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -34,120 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -32,270 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -25,408 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -24,570 | -100.00% | - | Jun 30, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 20,000 | -16,000 | -44.44% | 26,000 | Jun 30, 2024 |
| BROWN WEALTH MANAGEMENT, LLC | 0.14% | 0.05% | 100,000 | -10,000 | -9.09% | 130,000 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.04% | - | 30,544 | -8,500 | -21.77% | 39,707 | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -7,678 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.21% | - | 145,990 | -7,054 | -4.61% | 189,787 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.09% | 0.00% | 62,117 | -6,346 | -9.27% | 80,752 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 4 | -5,400 | -99.93% | 5 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.03% | 0.00% | 18,802 | -3,205 | -14.56% | 24,443 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,200 | -600 | -33.33% | 1,560 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 50 | -508 | -91.04% | 65 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.01% | 0.00% | 10,500 | -500 | -4.55% | 14,000 | Jun 30, 2024 |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | - | - | - | -385 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Clearside Biomedical's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -1.82M shares of CLSD, valued at $2.78M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASSENAGON ASSET MANAGEMENT S.A. | 0.41% | 0.00% | 283,193 | 283,193 | 100.00% | 368,151 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.03% | - | 20,788 | 20,788 | 100.00% | 27,024 | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.01% | - | 10,000 | 10,000 | 100.00% | 13,000 | Jun 30, 2024 |
| ROCKWOOD WEALTH MANAGEMENT, LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 13,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 568 | 568 | 100.00% | 1,000 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 243 | 243 | 100.00% | 316 | Jun 30, 2024 |
Clearside Biomedical's largest new institutional shareholder by number of shares is ASSENAGON ASSET MANAGEMENT S.A., purchased 283.19K shares, valued at $368.15K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | - | - | - | -169,629 | -100.00% | - | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | - | - | - | -161,962 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -34,120 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -32,270 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -25,408 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -24,570 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -7,678 | -100.00% | - | Jun 30, 2024 |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | - | - | - | -385 | -100.00% | - | Jun 30, 2024 |
Clearside Biomedical's largest sold out institutional shareholder by shares sold is JOHNSON & JOHNSON, sold -0.17M shares, valued at -, as of undefined.
Clearside Biomedical Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.35% | 165,330 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 33,500 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 130,200 | -45,400 | -25.85% | Mar 28, 2024 |
| ALGER FUNDS | 0.04% | 40,000 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,384,116 | -413,978 | -14.79% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 45,373 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 9,034 | - | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 468,920 | 14,546 | 3.20% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,371 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 20,216 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 54,600 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,604 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 50,000 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 3,760 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,748 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 5,658 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 5,062 | - | - | Feb 29, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 74,428 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 8,939 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 121,742 | -1,517 | -1.23% | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,289 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 500 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,115 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 948 | 203 | 27.25% | Mar 31, 2024 |
Clearside Biomedical's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 165.33K shares, compromising 0.35% of its total assets.
Clearside Biomedical Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -70.91% |
| 31 Mar, 24 | 55 | 12.24% |
| 31 Dec, 23 | 49 | -2.00% |
| 30 Sep, 23 | 50 | -12.28% |
| 30 Jun, 23 | 57 | 7.55% |
| 31 Mar, 23 | 53 | -7.02% |
| 31 Dec, 22 | 57 | 1.79% |
| 30 Sep, 22 | 56 | 1.82% |
| 30 Jun, 22 | 55 | -11.29% |
| 31 Mar, 22 | 62 | -11.43% |
| 31 Dec, 21 | 70 | -4.11% |
| 30 Sep, 21 | 73 | 19.67% |
| 30 Jun, 21 | 61 | 5.17% |
| 31 Mar, 21 | 58 | 41.46% |
| 31 Dec, 20 | 41 | - |
| 30 Sep, 20 | 41 | -10.87% |
| 30 Jun, 20 | 46 | 2.22% |
| 31 Mar, 20 | 45 | -11.76% |
| 31 Dec, 19 | 51 | 59.38% |
| 30 Sep, 19 | 32 | -31.91% |
| 30 Jun, 19 | 47 | -17.54% |
| 31 Mar, 19 | 57 | -18.57% |
| 31 Dec, 18 | 70 | -23.08% |
| 30 Sep, 18 | 91 | 1.11% |
| 30 Jun, 18 | 90 | 8.43% |
| 31 Mar, 18 | 83 | 56.60% |
| 31 Dec, 17 | 53 | 6.00% |
| 30 Sep, 17 | 50 | -3.85% |
| 30 Jun, 17 | 52 | -11.86% |
| 31 Mar, 17 | 59 | -4.84% |
| 31 Dec, 16 | 62 | 106.67% |
| 30 Sep, 16 | 30 | 87.50% |
| 30 Jun, 16 | 16 | - |
As of 30 Jun 24, 16 institutions are holding Clearside Biomedical's shares, representing a decrease of -70.91% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,250,027 | -72.63% |
| 31 Mar, 24 | 15,525,337 | 100.43% |
| 31 Dec, 23 | 7,745,921 | -1.18% |
| 30 Sep, 23 | 7,838,371 | -8.78% |
| 30 Jun, 23 | 8,593,115 | -1.75% |
| 31 Mar, 23 | 8,745,837 | -4.24% |
| 31 Dec, 22 | 9,133,458 | -24.39% |
| 30 Sep, 22 | 12,079,948 | -11.86% |
| 30 Jun, 22 | 13,705,280 | -16.29% |
| 31 Mar, 22 | 16,372,033 | -22.07% |
| 31 Dec, 21 | 21,008,588 | 3.88% |
| 30 Sep, 21 | 20,224,508 | 2.86% |
| 30 Jun, 21 | 19,662,373 | 10.86% |
| 31 Mar, 21 | 17,736,516 | 24.39% |
| 31 Dec, 20 | 14,258,923 | 19.08% |
| 30 Sep, 20 | 11,974,352 | 1.62% |
| 30 Jun, 20 | 11,782,964 | 2.54% |
| 31 Mar, 20 | 11,491,355 | 44.55% |
| 31 Dec, 19 | 7,949,911 | 13.68% |
| 30 Sep, 19 | 6,993,295 | 55.04% |
| 30 Jun, 19 | 4,510,766 | -26.45% |
| 31 Mar, 19 | 6,132,781 | -52.04% |
| 31 Dec, 18 | 12,786,544 | -31.10% |
| 30 Sep, 18 | 18,558,613 | -8.96% |
| 30 Jun, 18 | 20,384,501 | 3.79% |
| 31 Mar, 18 | 19,640,437 | 59.32% |
| 31 Dec, 17 | 12,327,559 | -5.83% |
| 30 Sep, 17 | 13,090,756 | -1.47% |
| 30 Jun, 17 | 13,285,825 | 8.85% |
| 31 Mar, 17 | 12,205,988 | 2.83% |
| 31 Dec, 16 | 11,870,294 | 49.67% |
| 30 Sep, 16 | 7,930,825 | 5.26% |
| 30 Jun, 16 | 7,534,407 | - |
Clearside Biomedical (CLSD) has 4.25M shares outstanding as of 30 Jun 24, down -72.63% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 6.08% | 0.96% |
| 31 Mar, 24 | 25.12% | 16.09% |
| 31 Dec, 23 | 12.50% | 7.73% |
| 30 Sep, 23 | 12.71% | 6.44% |
| 30 Jun, 23 | 14.05% | 6.87% |
| 31 Mar, 23 | 14.30% | 6.21% |
| 31 Dec, 22 | 15.17% | 3.77% |
| 30 Sep, 22 | 20.07% | 3.87% |
| 30 Jun, 22 | 22.79% | 3.07% |
| 31 Mar, 22 | 27.26% | 2.20% |
| 31 Dec, 21 | 35.21% | 3.04% |
| 30 Sep, 21 | 34.01% | 2.93% |
| 30 Jun, 21 | 34.05% | 3.52% |
| 31 Mar, 21 | 31.10% | 3.31% |
| 31 Dec, 20 | 30.66% | 4.72% |
| 30 Sep, 20 | 25.49% | 3.75% |
| 30 Jun, 20 | 26.06% | 3.95% |
| 31 Mar, 20 | 25.68% | 5.92% |
| 31 Dec, 19 | 20.83% | 6.28% |
| 30 Sep, 19 | 18.20% | 12.67% |
| 30 Jun, 19 | 11.99% | 3.72% |
| 31 Mar, 19 | 17.96% | 1.13% |
| 31 Dec, 18 | 39.91% | 1.19% |
| 30 Sep, 18 | 57.95% | 1.43% |
| 30 Jun, 18 | 63.74% | 1.19% |
| 31 Mar, 18 | 73.24% | 3.10% |
| 31 Dec, 17 | 48.64% | 1.82% |
| 30 Sep, 17 | 51.66% | 1.87% |
| 30 Jun, 17 | 52.49% | 2.25% |
| 31 Mar, 17 | 48.34% | 1.56% |
| 31 Dec, 16 | 55.60% | 4.03% |
| 30 Sep, 16 | 37.15% | 0.44% |
| 30 Jun, 16 | 91.39% | - |
As of 30 Jun 24, Clearside Biomedical is held by 6.08% institutional shareholders, representing a 0.96% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 7 | -77.42% |
| 31 Mar, 24 | 31 | 93.75% |
| 31 Dec, 23 | 16 | 33.33% |
| 30 Sep, 23 | 12 | -36.84% |
| 30 Jun, 23 | 19 | 18.75% |
| 31 Mar, 23 | 16 | -23.81% |
| 31 Dec, 22 | 21 | 61.54% |
| 30 Sep, 22 | 13 | - |
| 30 Jun, 22 | 13 | -43.48% |
| 31 Mar, 22 | 23 | -41.03% |
| 31 Dec, 21 | 39 | -11.36% |
| 30 Sep, 21 | 44 | 83.33% |
| 30 Jun, 21 | 24 | -33.33% |
| 31 Mar, 21 | 36 | 100.00% |
| 31 Dec, 20 | 18 | 12.50% |
| 30 Sep, 20 | 16 | -27.27% |
| 30 Jun, 20 | 22 | - |
| 31 Mar, 20 | 22 | -21.43% |
| 31 Dec, 19 | 28 | 180.00% |
| 30 Sep, 19 | 10 | -33.33% |
| 30 Jun, 19 | 15 | -21.05% |
| 31 Mar, 19 | 19 | -38.71% |
| 31 Dec, 18 | 31 | -38.00% |
| 30 Sep, 18 | 50 | -3.85% |
| 30 Jun, 18 | 52 | -20.00% |
| 31 Mar, 18 | 65 | 160.00% |
| 31 Dec, 17 | 25 | 8.70% |
| 30 Sep, 17 | 23 | -34.29% |
| 30 Jun, 17 | 35 | -2.78% |
| 31 Mar, 17 | 36 | -32.08% |
| 31 Dec, 16 | 53 | 152.38% |
| 30 Sep, 16 | 21 | 31.25% |
| 30 Jun, 16 | 16 | - |
7 institutional shareholders have increased their position in CLSD stock as of 30 Jun 24 compared to 31 in the previous quarter (a -77.42% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -66.67% |
| 31 Mar, 24 | 6 | -45.45% |
| 31 Dec, 23 | 11 | -26.67% |
| 30 Sep, 23 | 15 | 25.00% |
| 30 Jun, 23 | 12 | -7.69% |
| 31 Mar, 23 | 13 | -13.33% |
| 31 Dec, 22 | 15 | -31.82% |
| 30 Sep, 22 | 22 | -8.33% |
| 30 Jun, 22 | 24 | 14.29% |
| 31 Mar, 22 | 21 | 50.00% |
| 31 Dec, 21 | 14 | 40.00% |
| 30 Sep, 21 | 10 | -28.57% |
| 30 Jun, 21 | 14 | 100.00% |
| 31 Mar, 21 | 7 | -22.22% |
| 31 Dec, 20 | 9 | -10.00% |
| 30 Sep, 20 | 10 | - |
| 30 Jun, 20 | 10 | 25.00% |
| 31 Mar, 20 | 8 | -20.00% |
| 31 Dec, 19 | 10 | - |
| 30 Sep, 19 | 10 | -41.18% |
| 30 Jun, 19 | 17 | -15.00% |
| 31 Mar, 19 | 20 | -25.93% |
| 31 Dec, 18 | 27 | 35.00% |
| 30 Sep, 18 | 20 | -13.04% |
| 30 Jun, 18 | 23 | 155.56% |
| 31 Mar, 18 | 9 | -40.00% |
| 31 Dec, 17 | 15 | 66.67% |
| 30 Sep, 17 | 9 | - |
| 30 Jun, 17 | 9 | - |
| 31 Mar, 17 | 9 | 50.00% |
| 31 Dec, 16 | 6 | 50.00% |
| 30 Sep, 16 | 4 | - |
| 30 Jun, 16 | - | - |
2 institutional shareholders have reduced their position in CLSD stock as of 30 Jun 24 compared to 6 in the previous quarter (a -66.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 16 | -70.91% | 4,250,027 | -72.63% | 6.08% | 0.96% | 7 | -77.42% | 2 | -66.67% |
| 31 Mar, 24 | 55 | 12.24% | 15,525,337 | 100.43% | 25.12% | 16.09% | 31 | 93.75% | 6 | -45.45% |
| 31 Dec, 23 | 49 | -2.00% | 7,745,921 | -1.18% | 12.50% | 7.73% | 16 | 33.33% | 11 | -26.67% |
| 30 Sep, 23 | 50 | -12.28% | 7,838,371 | -8.78% | 12.71% | 6.44% | 12 | -36.84% | 15 | 25.00% |
| 30 Jun, 23 | 57 | 7.55% | 8,593,115 | -1.75% | 14.05% | 6.87% | 19 | 18.75% | 12 | -7.69% |
| 31 Mar, 23 | 53 | -7.02% | 8,745,837 | -4.24% | 14.30% | 6.21% | 16 | -23.81% | 13 | -13.33% |
| 31 Dec, 22 | 57 | 1.79% | 9,133,458 | -24.39% | 15.17% | 3.77% | 21 | 61.54% | 15 | -31.82% |
| 30 Sep, 22 | 56 | 1.82% | 12,079,948 | -11.86% | 20.07% | 3.87% | 13 | - | 22 | -8.33% |
| 30 Jun, 22 | 55 | -11.29% | 13,705,280 | -16.29% | 22.79% | 3.07% | 13 | -43.48% | 24 | 14.29% |
| 31 Mar, 22 | 62 | -11.43% | 16,372,033 | -22.07% | 27.26% | 2.20% | 23 | -41.03% | 21 | 50.00% |
| 31 Dec, 21 | 70 | -4.11% | 21,008,588 | 3.88% | 35.21% | 3.04% | 39 | -11.36% | 14 | 40.00% |
| 30 Sep, 21 | 73 | 19.67% | 20,224,508 | 2.86% | 34.01% | 2.93% | 44 | 83.33% | 10 | -28.57% |
| 30 Jun, 21 | 61 | 5.17% | 19,662,373 | 10.86% | 34.05% | 3.52% | 24 | -33.33% | 14 | 100.00% |
| 31 Mar, 21 | 58 | 41.46% | 17,736,516 | 24.39% | 31.10% | 3.31% | 36 | 100.00% | 7 | -22.22% |
| 31 Dec, 20 | 41 | - | 14,258,923 | 19.08% | 30.66% | 4.72% | 18 | 12.50% | 9 | -10.00% |
| 30 Sep, 20 | 41 | -10.87% | 11,974,352 | 1.62% | 25.49% | 3.75% | 16 | -27.27% | 10 | - |
| 30 Jun, 20 | 46 | 2.22% | 11,782,964 | 2.54% | 26.06% | 3.95% | 22 | - | 10 | 25.00% |
| 31 Mar, 20 | 45 | -11.76% | 11,491,355 | 44.55% | 25.68% | 5.92% | 22 | -21.43% | 8 | -20.00% |
| 31 Dec, 19 | 51 | 59.38% | 7,949,911 | 13.68% | 20.83% | 6.28% | 28 | 180.00% | 10 | - |
| 30 Sep, 19 | 32 | -31.91% | 6,993,295 | 55.04% | 18.20% | 12.67% | 10 | -33.33% | 10 | -41.18% |
| 30 Jun, 19 | 47 | -17.54% | 4,510,766 | -26.45% | 11.99% | 3.72% | 15 | -21.05% | 17 | -15.00% |
| 31 Mar, 19 | 57 | -18.57% | 6,132,781 | -52.04% | 17.96% | 1.13% | 19 | -38.71% | 20 | -25.93% |
| 31 Dec, 18 | 70 | -23.08% | 12,786,544 | -31.10% | 39.91% | 1.19% | 31 | -38.00% | 27 | 35.00% |
| 30 Sep, 18 | 91 | 1.11% | 18,558,613 | -8.96% | 57.95% | 1.43% | 50 | -3.85% | 20 | -13.04% |
| 30 Jun, 18 | 90 | 8.43% | 20,384,501 | 3.79% | 63.74% | 1.19% | 52 | -20.00% | 23 | 155.56% |
| 31 Mar, 18 | 83 | 56.60% | 19,640,437 | 59.32% | 73.24% | 3.10% | 65 | 160.00% | 9 | -40.00% |
| 31 Dec, 17 | 53 | 6.00% | 12,327,559 | -5.83% | 48.64% | 1.82% | 25 | 8.70% | 15 | 66.67% |
| 30 Sep, 17 | 50 | -3.85% | 13,090,756 | -1.47% | 51.66% | 1.87% | 23 | -34.29% | 9 | - |
| 30 Jun, 17 | 52 | -11.86% | 13,285,825 | 8.85% | 52.49% | 2.25% | 35 | -2.78% | 9 | - |
| 31 Mar, 17 | 59 | -4.84% | 12,205,988 | 2.83% | 48.34% | 1.56% | 36 | -32.08% | 9 | 50.00% |
| 31 Dec, 16 | 62 | 106.67% | 11,870,294 | 49.67% | 55.60% | 4.03% | 53 | 152.38% | 6 | 50.00% |
| 30 Sep, 16 | 30 | 87.50% | 7,930,825 | 5.26% | 37.15% | 0.44% | 21 | 31.25% | 4 | - |
| 30 Jun, 16 | 16 | - | 7,534,407 | - | 91.39% | - | 16 | - | - | - |
Clearside Biomedical Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Clearside Biomedical's stock was made by Chong Ngai Hang Victor on Jun 24 2024, selling - shares at - per share (valued at -). The last insider buy of CLSD was made by Chong Ngai Hang Victor on Jun 24 2024, buying 23,500 shares at $1.06 per share (worth $24.91K).
Clearside Biomedical Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 13 | - | - |
| Q1 2024 | 6 | 3 | 200.00% |
| Q4 2023 | 4 | 1 | 400.00% |
| Q3 2023 | 5 | 2 | 250.00% |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 3 | 4 | 75.00% |
| Q4 2022 | 5 | 2 | 250.00% |
| Q2 2022 | 10 | - | - |
| Q1 2022 | 12 | 6 | 200.00% |
| Q4 2021 | 2 | 2 | 100.00% |
| Q3 2021 | 1 | 6 | 16.67% |
| Q2 2021 | 6 | 2 | 300.00% |
| Q1 2021 | 9 | 4 | 225.00% |
| Q4 2020 | 4 | 1 | 400.00% |
| Q3 2020 | 5 | 1 | 500.00% |
| Q2 2020 | 8 | 6 | 133.33% |
| Q1 2020 | 5 | - | - |
| Q4 2019 | 3 | 1 | 300.00% |
| Q3 2019 | 3 | - | - |
| Q2 2019 | 8 | - | - |
13 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Clearside Biomedical's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 4 | - | - |
| Q1 2024 | 3 | 2 | 150.00% |
| Q4 2023 | 4 | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 4 | - |
| Q4 2022 | 2 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 4 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 1 | 6 | 16.67% |
| Q2 2021 | - | 2 | - |
| Q1 2021 | 2 | 4 | 50.00% |
| Q4 2020 | 4 | 1 | 400.00% |
| Q3 2020 | 5 | 1 | 500.00% |
| Q2 2020 | 1 | 2 | 50.00% |
| Q1 2020 | - | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 4 open market buy trades and 0 open market sell trades of Clearside Biomedical's stocks.
Clearside Biomedical Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| NUVB | Nuvation Bio Inc. |
| NXTC | NextCure, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| TNYA | Tenaya Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| SNSE | Sensei Biotherapeutics, Inc. |
| INBX | Inhibrx, Inc. |
| GBIO | Generation Bio Co. |
| OCUL | Ocular Therapeutix, Inc. |
| GRPH | LENZ Therapeutics, Inc. |
| KRON | Kronos Bio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ORIC | ORIC Pharmaceuticals, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| EYEN | Eyenovia, Inc. |
| DSGN | Design Therapeutics, Inc. |
| EPIX | ESSA Pharma Inc. |
| DRTS | Alpha Tau Medical Ltd. |
| LYRA | Lyra Therapeutics, Inc. |
| MACK | Merrimack Pharmaceuticals, Inc. |
CLSD Ownership FAQ
Who Owns Clearside Biomedical?
Clearside Biomedical is owned by institutional shareholders (6.08%), insiders (7.42%), and public (86.49%). The largest institutional shareholder of Clearside Biomedical is VANGUARD GROUP INC (4.07% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.35% of total shares).
Who are the major institutional shareholders of Clearside Biomedical?
Clearside Biomedical's major institutional shareholders are VANGUARD GROUP INC, ROSALIND ADVISORS, INC., ARMISTICE CAPITAL, LLC, CARMIGNAC GESTION, and BLACKROCK INC.. The top five shareholders own together 15.03% of the company's share outstanding.
How many Clearside Biomedical shareholders are there?
As of Jun 2024, there are 16 institutional shareholders of Clearside Biomedical.
What percentage of Clearside Biomedical is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 2.84M shares of Clearside Biomedical, representing 4.07% of the company's total shares outstanding, valued at $3.69M (as of Jun 2024).
What percentage of Clearside Biomedical is owned by ROSALIND ADVISORS, INC?
As of Jun 2024, ROSALIND ADVISORS, INC holds 2.59M shares of Clearside Biomedical (CLSD), compromising 3.71% of the company, valued at $3.37M.
What percentage of Clearside Biomedical is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC is the third largest holder of Clearside Biomedical. The company owns 2.14M of the company's shares outstanding (worth $2.78M).